STAT

As the March for Life approaches, anti-abortion leaders are rebranding as ‘pro-science.’ Scientists say otherwise

The March for Life, an annual anti-abortion demonstration, says that being “pro-life is pro-science.” So why is the movement attempting to oust the federal government’s top biomedical researcher?
Anti-abortion advocates in front of the U.S. Supreme Court during the 2017 March For Life.

WASHINGTON — When anti-abortion demonstrators numbering in the tens of thousands join the March for Life, an anti-abortion protest set to take place Friday on the National Mall here, many will tout signs bearing a new slogan: “Pro-life is pro-science.”

Much of the country’s mainstream scientific community would argue the opposite.

In recent months, anti-abortion advocates have advocated for the cancellation of a federal research contract for fetal tissue procurement and pushed to halt other research they view as immoral. The results: a $2 million project to test HIV drugs derailed and another pair of studies, including one to develop cancer immunotherapies, left in limbo. The movement’s latest objective: to force President Trump to fire the renowned director of the National Institutes of Health, Francis Collins, the country’s top biomedical research scientist.

“The segment of the community that’s against this type of the research has been there all along, but it’s just emboldened by this administration,” said Lawrence Goldstein, a University of California, San Diego, neuroscientist who uses fetal cells in his research. “This sort of thing has a chilling effect.”

The backers of the March for Life — along with other advocates who support similar anti-abortion causes — argue that their work is in fact “pro-science,” as their slogan confirms.

“Science needs to be at the service of life,” Jeanne Mancini, the March for Life president, told STAT in an interview, arguing that research involving human

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT1 min read
STAT+: Nuclear Regulatory Commission Advisers Beset By Conflicts Of Interest, Report Finds
Advisers to the Nuclear Regulatory Commission, a U.S. government agency tasked with ensuring the safe use of radioactive materials, were beset by conflicts of interest, report finds

Related Books & Audiobooks